These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25155313)

  • 21. Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors.
    Icht O; Darzi N; Shimony S; Jacobi O; Reinhorn D; Landman Y; Mutai R; Averbuch I; Shochat T; Spectre G; Raanani P; Rotem O; Dudnik E; Peled N; Zer A; Leader A
    J Thromb Haemost; 2021 May; 19(5):1250-1258. PubMed ID: 33605020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
    Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
    J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer.
    Dimakakos E; Livanios K; Vathiotis I; Gomatou G; Gkiozos I; Kotteas E; Kainis E; Syrigos K
    Anticancer Res; 2021 Mar; 41(3):1523-1528. PubMed ID: 33788745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Li J; Yi J; Hua L; Su Y; Huo M; Dou F; Zhai Z; Zhu M; Zhang S; Zhang Y
    Thromb Res; 2021 Dec; 208():45-51. PubMed ID: 34695715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
    Hill H; Robinson M; Lu L; Slaughter D; Amin A; Mileham K; Patel JN
    Thromb Res; 2021 Dec; 208():71-78. PubMed ID: 34742139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
    Wang M; Huang X; Zhu M; Zhang S; Zhang Y
    Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and impact of screening for venous thromboembolism in treatment-naive lung cancer patients-Results of a prospective cohort study.
    Muthu V; Narasimhan RL; Prasad KT; Ahluwalia J; Garg M; Behera D; Singh N
    Indian J Cancer; 2022; 59(2):203-211. PubMed ID: 33753627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients.
    He X; Wei SN; Qin WW; Geng N; Li B; Song S; Wang P
    Expert Rev Hematol; 2023; 16(12):1135-1142. PubMed ID: 37883026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
    Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
    J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer.
    Connolly GC; Dalal M; Lin J; Khorana AA
    Lung Cancer; 2012 Dec; 78(3):253-8. PubMed ID: 23026639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous Thromboembolism in Patents With Lung Cancer.
    Suzuki T; Fujino S; Inaba S; Yamamura R; Katoh H; Noji Y; Yamaguchi M; Aoyama T
    Clin Appl Thromb Hemost; 2020; 26():1076029620977910. PubMed ID: 33350315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
    Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
    J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
    Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and risk factors of VTE in lung cancer: a meta-analysis.
    Yang R; Wang H; Liu D; Li W
    Ann Med; 2024 Dec; 56(1):2390200. PubMed ID: 39183726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.
    Kourelis TV; Wysokinska EM; Wang Y; Yang P; Mansfield AS; Tafur AJ
    Lung Cancer; 2014 Dec; 86(3):358-62. PubMed ID: 25453848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
    Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
    J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.
    Dou F; Li H; Zhu M; Liang L; Zhang Y; Yi J; Zhang Y
    Respir Res; 2018 May; 19(1):88. PubMed ID: 29743116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
    Bjørnhart B; Kristiansen C; Asmussen J; Hansen KH; Wedervang K; Jørgensen TL; Herrstedt J; Schytte T
    Thromb Res; 2023 Jan; 221():164-172. PubMed ID: 36396518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.